| pubmed-article:15701208 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C0013395 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C0003211 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C1257954 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C0457454 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C1444662 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:15701208 | lifeskim:mentions | umls-concept:C0972314 | lld:lifeskim |
| pubmed-article:15701208 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:15701208 | pubmed:dateCreated | 2005-2-9 | lld:pubmed |
| pubmed-article:15701208 | pubmed:abstractText | Most nonsteroidal anti-inflammatory drugs (NSAIDs) are non-selective cyclooxygenase-1 (COX-1) and COX-2 inhibitors and are associated with upper gastrointestinal (GI) dyspeptic symptoms often resulting in GI co-medication usage or treatment discontinuation. | lld:pubmed |
| pubmed-article:15701208 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15701208 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15701208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15701208 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15701208 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:15701208 | pubmed:issn | 0300-7995 | lld:pubmed |
| pubmed-article:15701208 | pubmed:author | pubmed-author:YoII | lld:pubmed |
| pubmed-article:15701208 | pubmed:author | pubmed-author:WatsonD JDJ | lld:pubmed |
| pubmed-article:15701208 | pubmed:author | pubmed-author:CurtinTT | lld:pubmed |
| pubmed-article:15701208 | pubmed:author | pubmed-author:BologneseJ... | lld:pubmed |
| pubmed-article:15701208 | pubmed:author | pubmed-author:KrupaDD | lld:pubmed |
| pubmed-article:15701208 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15701208 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:15701208 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15701208 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15701208 | pubmed:pagination | 1899-908 | lld:pubmed |
| pubmed-article:15701208 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:meshHeading | pubmed-meshheading:15701208... | lld:pubmed |
| pubmed-article:15701208 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15701208 | pubmed:articleTitle | Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs. | lld:pubmed |
| pubmed-article:15701208 | pubmed:affiliation | Merck Research Laboratories, West Point, PA 19486, USA. douglas_watson@merck.com | lld:pubmed |
| pubmed-article:15701208 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15701208 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15701208 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15701208 | lld:pubmed |
